The better option of revascularization in complex coronary artery disease patients complicate with chronic kidney disease: a review and meta-analysis

X Chen, X Zhang, Y Yan, G Wang - Current Problems in Cardiology, 2021 - Elsevier
The treatment of complex coronary artery disease (CAD) combined with chronic kidney
disease (CKD) faces great challenges. We thus did a systematic review and meta-analysis …

Coronary revascularisation in patients with chronic kidney disease and end‐stage renal disease: A meta‐analysis

X Li, F Xiao, S Zhang - International journal of clinical practice, 2021 - Wiley Online Library
Objectives To compare coronary artery bypass grafting (CABG) and percutaneous coronary
intervention (PCI) for revascularising coronary arteries in patients with chronic kidney …

Impacts of Skeletonized Bilateral Internal Mammary Artery Bypass Grafting on the Risk of Deep Sternal Wound Infection Insights from a Single-Center Study of …

Q Ji, Y Zhao, H Liu, Y Yang, YL Wang… - International Heart …, 2020 - jstage.jst.go.jp
This single-center study aimed to evaluate the incidence of deep sternal wound infection
(DSWI) following skeletonized bilateral internal mammary artery (BIMA) harvest in a Chinese …

[HTML][HTML] Effect of multidimensional comprehensive intervention on medication compliance, social function and incidence of MACE in patients undergoing PCI

Y Zhang, Y Yang, J Xiao, Y Sun, S Yang… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: To analyze the effect of multidimensional comprehensive intervention on
medication compliance, social function and incidence of major adverse cardiovascular …

Comparison of long-term cardiovascular and renal outcomes between percutaneous coronary intervention and coronary artery bypass grafting in multi-vessel disease …

W Kwon, KH Choi, DS Jeong, SY Lee… - Frontiers in …, 2022 - frontiersin.org
Objective This study aims to analyze cardiac and renal outcomes of chronic kidney disease
(CKD) patients with multi-vessel disease who have undergone coronary artery bypass …

Perioperative variation in serum FGF-23 level and its correlation with MACCE risk in unprotected left main coronary artery disease patients receiving coronary artery …

F Wang, R Ma, C Wang - Frontiers in Surgery, 2022 - frontiersin.org
Objective Fibroblast growth factor-23 (FGF-23) mediates vascular endothelial injury,
inflammatory infiltration, and atherosclerosis, which could reflect major adverse cardiac and …

Comparison of coronary artery bypass grafting and drug-eluting stents in patients with left main coronary artery disease and chronic kidney disease: a systematic …

M Barbarawi, Y Zayed, K Hamid, B Kheiri… - Cardiovascular …, 2019 - Elsevier
Background Treatment of left main coronary artery disease (LMCAD) in patients with chronic
kidney disease (CKD) with either percutaneous coronary intervention (PCI) or coronary …

[PDF][PDF] 冠心病病人介入治疗围术期炎性因子变化及心肌损伤相关因素分析

左摇梅, 王端乐, 辛摇浩, 赵摇娟, 张建华 - 2023 - xuebao.bbmu.edu.cn
目的: 分析冠心病病人介入手术治疗后围术期炎性因子变化及导致心肌损伤的相关因素. 方法:
选取行经皮冠脉介入治疗的冠心病病人65 例作为研究对象, 根据介入治疗后围术期是否发生 …

[HTML][HTML] Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease …

T Almas, A Afzal, H Fatima, S Yaqoob, FA Jarullah… - IJC Heart & …, 2022 - Elsevier
Introduction Owing to its large area of supply, left main coronary artery disease (LMCAD)
has the highest mortality rate among coronary artery lesions, resulting in debate about its …

Clinical significance of high-sensitivity C-reactive protein in patients with preserved renal function following percutaneous coronary intervention

T Shimizu, S Suwa, T Dohi, H Wada… - International Heart …, 2019 - jstage.jst.go.jp
Although high-sensitivity C-reactive protein (hs-CRP) has been used to predict the risk of
adverse cardiac events in patients with coronary artery disease (CAD) after percutaneous …